NCT00202878
IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103)
See it on ClinicalTrials.gov ↗18,144 people
24.3%
75.7%
4,416 womenmiddle line = equal numbers13,728 men
- Phase
- PHASE3
- Paid for by
- Organon and Co
- Finished
- 2014-09-18
- Health conditions
- Hypercholesterolemia, Myocardial Infarction
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 63.6 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnant or lactating woman, or intending to become pregnant”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnant or lactating woman, or intending to become pregnant”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Participant with active liver disease or persistent unexplained serum transaminase elevation”
Study titles and rules are shown in their original English.